Arur Footwear Navigates Post-CIRP Challenges with Fines and Pending Listing

Arur Footwear Limited, formerly S R Industries Limited, has reported procedural compliance deviations and fines totaling ₹11,800 during its annual secretarial compliance for FY2025-26. The company is currently in a post-Corporate Insolvency Resolution Process (CIRP) stabilization phase, with crucial listing approvals and demat share credits pending.

Reader Takeaway: Fines for compliance delays; pending listing approval impacts liquidity.

What just happened

The company disclosed that it incurred a fine of ₹11,800 from BSE Limited due to a delay in submitting XBRL voting results for the quarter ended June 2025. Additionally, the company faced Standard Operating Procedure (SOP) fines in November 2025 for delayed submissions of quarterly compliances (Regulations 13(3), 31, and 33(3) of SEBI LODR) for the quarter ended September 2024. Management attributed these issues to the transition and revival phase post-CIRP and stated they have been rectified.

Why this matters

These compliance lapses, though described as legacy issues, highlight ongoing operational challenges. More significantly, the company is awaiting crucial listing approval for its newly allotted equity shares following a corporate restructuring. Until this approval is granted, the company's ISIN remains suspended, and existing shareholders have not received their shares in demat accounts. This directly impacts the liquidity and tradability of the stock.

The backstory

Arur Footwear underwent significant restructuring after its Resolution Plan was approved by the NCLT on July 01, 2024, and executed on February 04, 2025. This involved the cancellation of erstwhile promoter shareholding and the allotment of new equity. New promoters, Bazel International Limited and associates, received 95% of the new equity, while existing public shareholders received the remaining 5%.

What changes now

The company is actively engaging with BSE Limited and other intermediaries to secure the pending listing approval. The focus is on completing these formalities to enable the credit of shares to demat accounts and lift the ISIN suspension. Resolution of these pending matters is critical for normal market operations.

Risks to watch

The primary risk for investors is the continued delay in listing approval, which prolongs the suspension of the ISIN and the inability to trade shares. Any further compliance issues or delays in regulatory approvals could exacerbate this situation. The concentration of new promoter equity at 95% also indicates a significant change in control and potential future strategic direction.

Context metrics (time-bound)

• Fine Amount: ₹11,800 for delayed XBRL voting results (June 2025 quarter).
• SOP Fines: Levied in November 2025 for delayed quarterly compliances (September 2024 quarter).
• Resolution Plan Execution: February 04, 2025.
• NCLT Approval: July 01, 2024.
• New Promoter Equity: 95% (Bazel International Limited and associates).
• Public Shareholder Equity: 5%.